ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO334

Sodium Magnetic Resonance Imaging Shows Impairment of the Counter-Current Multiplication System in the Diabetic Model Mice Kidney

Session Information

Category: Fluid‚ Electrolyte‚ and Acid-Base Disorders

  • 1001 Fluid‚ Electrolyte‚ and Acid-Base Disorders: Basic


  • Nakagawa, Yusuke, Niigata University, Niigata, Japan
  • Kaseda, Ryohei, Niigata University, Niigata, Japan
  • Suzuki, Yuya, Niigata University, Niigata, Japan
  • Terada, Yasuhiko, Tsukuba University, Tsukuba, Japan
  • Haishi, Tomoyuki, International University of Health and Welfare, Narita, Japan
  • Sasaki, Susumu, Niigata University, Niigata, Japan
  • Narita, Ichiei, Niigata University, Niigata, Japan

Sodium Magnetic Resonance Imaging (23Na-MRI) is a technique for imaging 23Na. It is possible to non-invasively assess sodium distributions, especially sodium concentration in the counter-current multiplication system in the kidney, which forms a sodium concentration gradient from the cortex to the medulla, enabling efficient water reabsorption. Although knowledge regarding the mechanisms of sodium reabsorption through channels or transporters has been accumulated, the distribution of the sodium concentration in the entire kidney has not been delineated in kidney diseases. Applying 23Na-MRI to disease model mice may expand the scope of prior studies and elucidate the pathogenesis of sodium gradient impairments. We investigated whether 23Na-MRI can detect changes in sodium concentrations under normal conditions in mice and in disease models such as a mouse model with diabetes mellitus.


23Na-MRI was performed with a 9.4T vertical standard-bore super-conducting magnet using C57BL/6JJcl administrated of furosemide (10 mg/kg BW), BKS.Cg-Leprdb+/+ Leprdb/Jcl (db/db) mice and its corresponding control BKS.Cg-m+/m+/Jcl (m+/m+) mice. The sodium gradient of the kidney between the cortex and medulla was compared.


The corticomedullary sodium gradient of the kidney significantly decreased 20 min after administration of furosemide, an NKCC2 inhibitor involved in the formation of the counter-current multiplication system (pre-1.53±0.16, post-2.19±0.3, P<0.05, N=7). The signal intensity of the medullary region in the kidney was lower in db/db mice (db/db 209.6±42.4 mmol/L, m+/m+ 333.5±54.4 mmol/L, P<0.01, N=7 each) and the corticomedullary sodium gradient of db/db mice was significantly decreased compared to m+/m+ mice (db/db 1.64±0.36, m+m+ 2.28±0.21, P<0.01).


23Na-MRI revealed reductions in the corticomedullary sodium gradients and impairment in the counter-current multiplication system in db/db mice at very early stages of diabetes mellitus. 23Na-MRI may be useful for diagnosing diabetic kidney disease and elucidating the pathogenesis of sodium gradient impairments.


  • Government Support – Non-U.S.